5 Recommendations for data collection

5 Recommendations for data collection

5.1 Proposals for further data collection in the Cancer Drugs Fund include further evidence on:

  • overall survival

  • progression-free survival

  • time to treatment discontinuation, and

  • the comparative effectiveness.

  • National Institute for Health and Care Excellence (NICE)